<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02410317</url>
  </required_header>
  <id_info>
    <org_study_id>Eudract 2014-002044-41</org_study_id>
    <nct_id>NCT02410317</nct_id>
  </id_info>
  <brief_title>Ropivacaine Through Continuous Infusion Versus Epidural Morphine for Postoperative Analgesia After Emergency Cesarean Section</brief_title>
  <acronym>ROMANCE</acronym>
  <official_title>Ropivacaine Through Continuous Infusion Versus Epidural Morphine for Postoperative Analgesia After Emergency Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The cesarean section is one of the most commonly performed surgeries in the world and it
      represents 20% of the births in France. Postoperative pain is moderate-to-severe during the
      first 48 hours after this procedure. Thereby its control is prominent for the medical team in
      order to shorten the duration of hospital stay as well as to permit an early return to daily
      activities for these surgical patients.

      Pain control after cesarean section is usually based on non-opioids and epidural
      administration of morphine if an epidural catheter has been previously placed for the
      procedure. However epidural morphine is associated with a number of side effects. Wound
      infiltration with local anesthetics has been widely used in the multimodal management of
      postoperative pain and it may reduce postoperative morphine consumption.

      In patients enrolled for emergency cesarean delivery with epidural catheter, the objective of
      this study will be to compare the analgesia provided by a local anesthetic wound 48-hours
      infusion through a multiorifice catheter (ropivacaine 2 mg/mL) versus epidural analgesia
      (epidural morphine bolus). Quality of pain control will be assessed with the measurements of
      morphine consumption and pain scores at rest and during mobilisation over 48 hours. At 3
      months, patients will be interviewed to assess their residual pain and their satisfaction.

      It is hypothesized that local anesthetic wound infusion would be non-inferior than epidural
      morphine analgesia to control pain after cesarean section, and be associated with a reduction
      of side effects related to the analgesics.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    expired insurance
  </why_stopped>
  <start_date type="Actual">February 2015</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score during mobilization</measure>
    <time_frame>at 24 hours</time_frame>
    <description>Visual analog scale for pain while the patient moves from lying to sitting</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score at rest</measure>
    <time_frame>at 2, 6(+/-1h), 12(+/-1h), 24(+/-2h), and 48 hours (+/-3h)</time_frame>
    <description>Visual analog scale for pain while the patient is at rest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score during mobilization</measure>
    <time_frame>at 2, 6(+/-1h), 12(+/-1h), 24(+/-2h), and 48 hours (+/-3h)</time_frame>
    <description>Visual analog scale for pain while the patient moves from lying to sitting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of morphine side effects: nausea, vomiting, pruritus</measure>
    <time_frame>at 2, 6(+/-1h), 12(+/-1h), 24(+/-2h), and 48 hours (+/-3h)</time_frame>
    <description>At every time points, side effects will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Indwelling Urethral Catheters</measure>
    <time_frame>at 2, 6(+/-1h), 12(+/-1h), 24(+/-2h), and 48 hours (+/-3h)</time_frame>
    <description>At ever time points, the presence of urethral catheter will be recorded and total duration will be compared.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recovery of bowel function</measure>
    <time_frame>at 2, 6(+/-1h), 12(+/-1h), 24(+/-2h), and 48 hours (+/-3h)</time_frame>
    <description>At ever time points, patients will be asked whether they recovered bowel function and total duration to recover bowel function will be compared.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morphine consumption dose</measure>
    <time_frame>During hospital stay (an average of 3 days)</time_frame>
    <description>Total dose of morphine consumed for pain management after the epidural bolus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parturient satisfaction score</measure>
    <time_frame>at 48 hours</time_frame>
    <description>Satisfaction about pain management and breastfeeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications during wound-catheter removal</measure>
    <time_frame>at 48 hours</time_frame>
    <description>Fever, pain, difficulties and infection at removal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delay between birth and breastfeeding</measure>
    <time_frame>During hospital stay (an average of 3 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of stay</measure>
    <time_frame>Hospital stay (an average of 3 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Residual pain</measure>
    <time_frame>3 months</time_frame>
    <description>Numeric Rating Scale for Pain by phone interview</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Continuous wound infusion group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive analgesia through a multiorifice wound catheter connected to ropivacaine infusion. Saline solution is given in the epidural bolus.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epidural morphine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive epidural analgesia through an epidural bolus of morphine. Saline solution is perfused through the wound catheter.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <arm_group_label>Continuous wound infusion group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <arm_group_label>Epidural morphine group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Minimum age 18 years

          -  ASA-1 and 2 Parturient

          -  Emergency Cesarean delivery under epidural anesthesia

          -  Suprapubic incision used for cesarean section

          -  Functional epidural Catheter before the cesarean decision

        (ASA Scores : Physical Status score)

        Exclusion Criteria:

          -  ASA-3 and 4 Parturient

          -  BMI &gt; 30 (before pregnancy)

          -  Existing chronic pain

          -  Contra-indication to study treatments

          -  Chronic use of analgesics or morphinic

          -  Preeclampsia

          -  Infection

          -  &lt; 37 weeks pregnant +/- 3 days
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>HÃ´pital Couple Enfant - CHU de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Fuller JG, McMorland GH, Douglas MJ, Palmer L. Epidural morphine for analgesia after caesarean section: a report of 4880 patients. Can J Anaesth. 1990 Sep;37(6):636-40.</citation>
    <PMID>2208533</PMID>
  </reference>
  <reference>
    <citation>Palmer CM, Nogami WM, Van Maren G, Alves DM. Postcesarean epidural morphine: a dose-response study. Anesth Analg. 2000 Apr;90(4):887-91.</citation>
    <PMID>10735794</PMID>
  </reference>
  <reference>
    <citation>Bamigboye AA, Hofmeyr GJ. Local anaesthetic wound infiltration and abdominal nerves block during caesarean section for postoperative pain relief. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006954. doi: 10.1002/14651858.CD006954.pub2. Review.</citation>
    <PMID>19588413</PMID>
  </reference>
  <reference>
    <citation>Mecklem DW, Humphrey MD, Hicks RW. Efficacy of bupivacaine delivered by wound catheter for post-Caesarean section analgesia. Aust N Z J Obstet Gynaecol. 1995 Nov;35(4):416-21.</citation>
    <PMID>8717568</PMID>
  </reference>
  <reference>
    <citation>Ranta PO, Ala-Kokko TI, Kukkonen JE, Ohtonen PP, Raudaskoski TH, Reponen PK, Rawal N. Incisional and epidural analgesia after caesarean delivery: a prospective, placebo-controlled, randomised clinical study. Int J Obstet Anesth. 2006 Jul;15(3):189-94.</citation>
    <PMID>16798442</PMID>
  </reference>
  <reference>
    <citation>O'Neill P, Duarte F, Ribeiro I, Centeno MJ, Moreira J. Ropivacaine continuous wound infusion versus epidural morphine for postoperative analgesia after cesarean delivery: a randomized controlled trial. Anesth Analg. 2012 Jan;114(1):179-85. doi: 10.1213/ANE.0b013e3182368e87. Epub 2011 Oct 24.</citation>
    <PMID>22025490</PMID>
  </reference>
  <reference>
    <citation>Siddik SM, Aouad MT, Jalbout MI, Rizk LB, Kamar GH, Baraka AS. Diclofenac and/or propacetamol for postoperative pain management after cesarean delivery in patients receiving patient controlled analgesia morphine. Reg Anesth Pain Med. 2001 Jul-Aug;26(4):310-5.</citation>
    <PMID>11464348</PMID>
  </reference>
  <reference>
    <citation>Rackelboom T, Le Strat S, Silvera S, Schmitz T, Bassot A, Goffinet F, Ozier Y, Beaussier M, Mignon A. Improving continuous wound infusion effectiveness for postoperative analgesia after cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2010 Oct;116(4):893-900. doi: 10.1097/AOG.0b013e3181f38ac6.</citation>
    <PMID>20859153</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2015</study_first_submitted>
  <study_first_submitted_qc>April 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2015</study_first_posted>
  <last_update_submitted>April 26, 2018</last_update_submitted>
  <last_update_submitted_qc>April 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Postoperative pain</keyword>
  <keyword>Postoperative morphine consumption</keyword>
  <keyword>Emergency cesarean delivery</keyword>
  <keyword>Ropivacaine</keyword>
  <keyword>Local anesthetic wound 48-hours infusion</keyword>
  <keyword>Emergency cesarean section</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

